Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:519-526
Published online before print December 20, 2007, doi: 10.1161/ATVBAHA.107.159467
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Additional Materials
Right arrow All Versions of this Article:
28/3/519    most recent
ATVBAHA.107.159467v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X.
Right arrow Articles by Chen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X.
Right arrow Articles by Chen, C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:519.)
© 2008 American Heart Association, Inc.


Cell Biology/Signaling

C-Reactive Protein Inhibits Cholesterol Efflux From Human Macrophage-Derived Foam Cells

Xinwen Wang; Dan Liao; Uddalak Bharadwaj; Min Li; Qizhi Yao; Changyi Chen

From the Molecular Surgeon Research Center, Division of Vascular Surgery and Endovascular Therapy (X.W., D.L., U.B., M.L., Q.Y., C.C.), Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex; and the Department of Vascular Surgery (X.W.), 1st Teaching Hospital, China Medical University, Shenyang, China.

Correspondence to Changyi (Johnny) Chen, MD, PhD, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail stop: NAB-2010, Houston, TX 77030. E-mail jchen{at}bcm.tmc.edu

Objective— The objective of this study was to determine the effects and potential mechanisms of C-reactive protein (CRP) on cholesterol efflux from human macrophage foam cells, which may play a critical role in atherogenesis.

Methods and Results— Human THP-1 monocytes and peripheral blood mononuclear cells (PBMCs) were preincubated with acetylated LDL and [3H]-cholesterol to form foam cells, which were then treated with apolipoprotein A-I (apoA-I) or HDL for cholesterol efflux assay. Clinically relevant concentrations of CRP significantly reduced cholesterol efflux from THP-1 and PBMCs to apoA-I or HDL. CRP significantly decreased the expression of ATP-binding membrane cassette transporter A-1 (ABCA1) and ABCG1, whereas it increased superoxide anion production. Futhermore, CRP substantially activated ERK1/2 in THP-1–derived foam-like cells. Reducing superoxide anion by antioxidant seleno-L-methionine or SOD mimetic (MnTBAP) effectively abolished the CRP-induced decrease in cholesterol efflux and the expression of ABCA1 and ABCG1. Inhibiting ERK1/2 activation by its specific inhibitor PD98059 or by a dominant negative mutant of ERK2 could also block CRPs action on THP-1 cells.

Conclusions— CRP inhibits cholesterol efflux from human foam cells derived from THP-1 and PBMCs in vitro though oxidative stress, ERK1/2 activation, and downregulation of intracellular cholesterol transport molecules ABCA1 and ABCG1.

The objective of this study was to determine the effects and potential mechanisms of C-reactive protein (CRP) on cholesterol efflux from human macrophage foam cells, which may play a critical role in atherogenesis. CRP inhibits cholesterol efflux from human foam cells derived from THP-1 and PBMCs in vitro though oxidative stress, ERK1/2 activation, and downregulation of intracellular cholesterol transport molecules ABCA-1 and ABCG-1.


Key Words: C-reactive protein • macrophage • cholesterol efflux • ATP-binding membrane cassette transporter • superoxide anion • antioxidant




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
X. Wang, H. Chai, P. H. Lin, Q. Yao, and C. Chen
Roles and Mechanisms of Human Immunodeficiency Virus Protease Inhibitor Ritonavir and Other Anti-Human Immunodeficiency Virus Drugs in Endothelial Dysfunction of Porcine Pulmonary Arteries and Human Pulmonary Artery Endothelial Cells
Am. J. Pathol., March 1, 2009; 174(3): 771 - 781.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Devaraj, U. Singh, and I. Jialal
The Evolving Role of C-Reactive Protein in Atherothrombosis
Clin. Chem., February 1, 2009; 55(2): 229 - 238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Wang, H. Chai, Z. Wang, P. H. Lin, Q. Yao, and C. Chen
Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2399 - H2408.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Montecucco, S. Steffens, F. Burger, G. Pelli, C. Monaco, and F. Mach
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes
J. Leukoc. Biol., October 1, 2008; 84(4): 1109 - 1119.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. Maingrette, L. Li, and G. Renier
C-reactive protein enhances macrophage lipoprotein lipase expression
J. Lipid Res., September 1, 2008; 49(9): 1926 - 1935.
[Abstract] [Full Text] [PDF]